Rational design and synthesis of highly potent β-glucocerebrosidase inhibitors

被引:92
|
作者
Zhu, XX
Sheth, KA
Li, SH
Chang, HH
Fan, JQ
机构
[1] Mt Sinai Sch Med, Dept Human Genet, New York, NY 10029 USA
[2] Amicus Therapeut Inc, Cranbury, NJ 08512 USA
关键词
biological activity; drug design; enzymes; inhibitors; natural products;
D O I
10.1002/anie.200502662
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
(Chemical Equation Presented) Highly potent human β-glucocerebrosidase inhibitors have been synthesized that appear to recognize both carbohydrate and hydrophobic binding sites. The most potent inhibitor, 6-nonyl isofagomine (see formula), shows an IC50 value at subnanomolar concentrations. These compounds are potential candidates for the development of small-molecule drugs for the treatment of Gaucher disease. © 2005 Wiley-VCH Verlag GmbH & Co. KGaA.
引用
收藏
页码:7450 / 7453
页数:4
相关论文
共 50 条
  • [41] SYNTHESIS OF GLUCOSYLCERAMIDE ANALOGS - IMINO-LINKED 5A-CARBAGLYCOSYLCERAMIDES, POTENT AND SPECIFIC GLUCOCEREBROSIDASE INHIBITORS
    OGAWA, S
    TSUNODA, H
    INOKUCHI, J
    JOURNAL OF THE CHEMICAL SOCIETY-CHEMICAL COMMUNICATIONS, 1994, (11) : 1317 - 1318
  • [42] Rational design and synthesis of aminopiperazinones as β-secretase (BACE) inhibitors
    Tresadern, Gary
    Delgado, Francisca
    Delgado, Oscar
    Gijsen, Harrie
    Macdonald, Gregor J.
    Moechars, Dieder
    Rombouts, Frederik
    Alexander, Richard
    Spurlino, John
    Van Gool, Michiel
    Antonio Vega, Juan
    Trabanco, Andres A.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2011, 21 (24) : 7255 - 7260
  • [43] Rational design and synthesis of thymidine phosphorylase inhibitors.
    McNally, VA
    Williams, KJ
    Bryce, R
    Stratford, IJ
    Jaffar, M
    Freeman, S
    CLINICAL CANCER RESEARCH, 2001, 7 (11) : 3748S - 3748S
  • [44] Rational design of potent and selective inhibitors of Pseudomonas aeruginosa virulence factor Cif
    Kitamura, Seiya
    Hvorecny, Kelli
    Madden, Dean
    Hammock, Bruce
    Morisseau, Christophe
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2015, 250
  • [45] The design, synthesis, and application of potent inhibitors of glucosylceramide synthase
    Shayman, JA
    Abe, A
    Lee, L
    GLYCOBIOLOGY, 1999, 9 (10) : 1110 - 1110
  • [46] Design and synthesis of chitin synthase inhibitors as potent fungicides
    Chen, Qi
    Zhang, Ji-Wei
    Chen, Lu-Lu
    Yang, Jun
    Yang, Xin-Ling
    Ling, Yun
    Yang, Qing
    CHINESE CHEMICAL LETTERS, 2017, 28 (06) : 1232 - 1237
  • [47] Design, synthesis and biological evaluation of potent FAAH inhibitors
    Tuo, Wei
    Leleu-Chavain, Natascha
    Barczyk, Amelie
    Renault, Nicolas
    Lemaire, Lucas
    Chavatte, Philippe
    Millet, Regis
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2016, 26 (11) : 2701 - 2705
  • [48] Rational Design of Potent Inhibitors of a Metallohydrolase Using a Fragment-Based Approach
    Feder, Daniel
    Mohd-Pahmi, Siti H.
    Hussein, Waleed M.
    Guddat, Luke W.
    McGeary, Ross P.
    Schenk, Gerhard
    CHEMMEDCHEM, 2021, 16 (21) : 3342 - 3359
  • [49] RATIONAL DESIGN OF POTENT, BIOAVAILABLE, NONPEPTIDE CYCLIC UREAS AS HIV PROTEASE INHIBITORS
    LAM, PYS
    JADHAV, PK
    EYERMANN, CJ
    HODGE, CN
    RU, Y
    BACHELER, LT
    MEEK, JL
    OTTO, MJ
    RAYNER, MM
    WONG, YN
    CHANG, CH
    WEBER, PC
    JACKSON, DA
    SHARPE, TR
    ERICKSONVIITANEN, S
    SCIENCE, 1994, 263 (5145) : 380 - 384
  • [50] The Rational Design of Glycoprotein-based Cryoprotectants that are Potent Inhibitors of Ice Recrystallization
    Ben, R. N.
    Leclerc, M.
    Wu, L.
    Allan, D. S.
    BIOPOLYMERS, 2011, 96 (04) : 421 - 421